Daewoong Co., Ltd. (KRX:003090)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,950
-500 (-1.82%)
At close: Feb 27, 2026
26.23%
Market Cap 1.10T
Revenue (ttm) 2.06T
Net Income (ttm) 77.51B
Shares Out 40.89M
EPS (ttm) 1,895.73
PE Ratio 14.22
Forward PE n/a
Dividend 200.00 (0.74%)
Ex-Dividend Date Dec 29, 2025
Volume 130,278
Average Volume 165,383
Open 26,950
Previous Close 27,450
Day's Range 26,600 - 28,100
52-Week Range 17,420 - 30,600
Beta 0.43
RSI 56.84
Earnings Date Mar 6, 2026

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, So... [Read more]

Sector Healthcare
Founded 1945
Employees 379
Stock Exchange Korea Stock Exchange
Ticker Symbol 003090
Full Company Profile

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.

Financial Statements

News

AEON Biopharma Completes BPD Type 2a Meeting With FDA

(RTTNews) - AEON Biopharma, Inc. (AEON), a biopharmaceutical company that develops ABP-450 as a biosimilar to BOTOX, reported that it held a BPD Type 2a meeting with the FDA in addition to the closure...

5 weeks ago - Nasdaq